Vascular Complications in Diabetes: Old Messages, New Thoughts
Forbes JM, Fotheringham AK
Diabetologia. 2017;60(11):2129-38
Leggi
Blu
Le Breaking News di colore blu sono relative ad abstract di articoli originali di particolare rilevanza.
Effect of Population Screening for Type 2 Diabetes And Cardiovascular Risk Factors On Mortality Rate And Cardiovascular Events: A Controlled Trial Among 1,912,392 Danish Adults
Simmons RK, Griffin SJ, Witte DR, et al.
Diabetologia. 2017;60(11):2183-91
Leggi
Effect of Screening for Type 2 Diabetes On Risk Of Cardiovascular Disease And Mortality: A Controlled Trial Among 139,075 Individuals Diagnosed With Diabetes In Denmark Between 2001 And 2009
Simmons RK, Griffin SJ, Lauritzen T, et al.
Diabetologia. 2017;60(11):2192-9
Leggi
Inpatient Glucose Values: Determining the Nondiabetic Range and Use in Identifying Patients at High Risk for Diabetes
Rhee MK, Safo SE, Jackson SLM, et al.
The American Journal of Medicine. Pub. online: October 6, 2017
Leggi
Exenatide Once Weekly Versus Placebo in Parkinson’s Disease: A Randomised, Double-Blind, Placebo-Controlled Trial
Athauda D, Maclagan K, Skene SS, et al.
The Lancet. 2017;390(10103):1664-75
Leggi
Insulin Signalling: New Target for Parkinson’s Treatments?
Poewe W, Seppi K
The Lancet. 2017;390(10103):1628-30
Leggi
Clinical Implications of Echocardiographic Phenotypes of Patients With Diabetes Mellitus
Ernande L, Audureau E, Jellis CL, et al.
J Am Coll Cardiol 2017;70(14):1704-16
Leggi
Cardiac Involvement in DiabetesThe Dark Side of the Moon
Galderisi M, Esposito R, Trimarco B
J Am Coll Cardiol 2017;70(14):1717-9
Leggi
Challenges in Choosing a Medication for Type 2 Diabetes
Rodríguez-Gutiérrez R, Salcido-Montenegro A, Elizondo-Plazas A, et al.
Diabetes Technol Ther. Pub. online September 2017
Leggi
Excessive Weight Gain, Obesity and Cancer. Opportunities for Clinical Intervention
Massetti GM, Dietz WH, Richardson LC
JAMA. Pub. online October 3, 2017
Leggi